| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | 17/09 | 55,81% |
| UBS (LUX) EQUITY FUND - TECH OPPORTUNITY (USD) Q-ACC | 17/09 | 55,81% |
| CAPITAL GROUP EUROPEAN CORE EQUITY FUND (LUX) Z EUR | 17/09 | 55,80% |
| BLACKROCK SYSTEMATIC ASIA PACIFIC EQUITY ABSOLUTE RETURN A2 EUR HEDGED | 17/09 | 55,79% |
| CT (LUX) AMERICAN EXTENDED ALPHA 3U USD | 17/09 | 55,79% |
| AMUNDI FUNDS US EQUITY RESEARCH E2 EUR (C) | 17/09 | 55,78% |
| MFS MERIDIAN EUROPEAN RESEARCH FUND IH1-USD | 17/09 | 55,78% |
| SCHRODER ISF EMERGING MARKETS X2 ACC USD | 17/09 | 55,78% |
| SPDR STOXX EUROPE 600 SRI UCITS ETF ACC | 17/09 | 55,77% |
| JANUS HENDERSON HF - JAPAN OPPORTUNITIES H2 USD | 17/09 | 55,76% |
| SABADELL EUROACCION, FI PYME | 17/09 | 55,76% |
| WELLINGTON GLOBAL RESEARCH EQUITY D USD ACC | 17/09 | 55,75% |
| AMUNDI FUNDS US EQUITY RESEARCH A EUR (C) | 17/09 | 55,74% |
| IBERCAJA JAPON, FI A | 17/09 | 55,74% |
| CAPITAL GROUP INVESTMENT COMPANY OF AMERICA (LUX) BH EUR | 17/09 | 55,73% |
| BNP PARIBAS EASY MSCI EUROPE MIN TE TRACK PRIVILEGE CAP | 16/09 | 55,71% |
| CT (LUX) AMERICAN EXTENDED ALPHA 8E EUR | 17/09 | 55,70% |
| JPM JAPAN EQUITY D (ACC) EUR (HEDGED) | 17/09 | 55,70% |
| RBC FUNDS (LUX)-EMERGING MARKETS EQUITY FUND A CAP USD | 17/09 | 55,70% |
| VANGUARD FTSE DEVELOPED EUROPE EX UK UCITS ETF EUR ACC | 17/09 | 55,69% |
